000 | 01527 a2200433 4500 | ||
---|---|---|---|
005 | 20250516003808.0 | ||
264 | 0 | _c20110427 | |
008 | 201104s 0 0 eng d | ||
022 | _a1873-5592 | ||
024 | 7 |
_a10.2174/138945011794182719 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDas, R A | |
245 | 0 | 0 |
_aCombined treatment modalities for age related macular degeneration. _h[electronic resource] |
260 |
_bCurrent drug targets _cFeb 2011 |
||
300 |
_a182-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAngiogenesis Inhibitors _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBlindness _xetiology |
650 | 0 | 4 |
_aChoroidal Neovascularization _xdrug therapy |
650 | 0 | 4 |
_aCombined Modality Therapy _xtrends |
650 | 0 | 4 |
_aDexamethasone _xtherapeutic use |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 |
_aGlucocorticoids _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMacular Degeneration _xdrug therapy |
650 | 0 | 4 | _aPhotochemotherapy |
650 | 0 | 4 |
_aPhotosensitizing Agents _xpharmacology |
650 | 0 | 4 |
_aPorphyrins _xpharmacology |
650 | 0 | 4 |
_aVascular Endothelial Growth Factors _xantagonists & inhibitors |
650 | 0 | 4 | _aVerteporfin |
650 | 0 | 4 |
_aWet Macular Degeneration _xdrug therapy |
700 | 1 | _aRomano, A | |
700 | 1 | _aChiosi, F | |
700 | 1 | _aMenzione, M | |
700 | 1 | _aRinaldi, M | |
773 | 0 |
_tCurrent drug targets _gvol. 12 _gno. 2 _gp. 182-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2174/138945011794182719 _zAvailable from publisher's website |
999 |
_c20215349 _d20215349 |